Drug Profile
Axogenesis factor 1
Alternative Names: AF-1Latest Information Update: 18 Oct 2007
Price :
$50
*
At a glance
- Originator Childrens Hospital Boston
- Developer Alseres Pharmaceuticals
- Class Nerve growth factors; Neuroprotectants
- Mechanism of Action Neuron stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Spinal cord injuries; Stroke